Iteos Therapeutics logo

Iteos Therapeutics share price today

(ITOS)

Iteos Therapeutics share price is $8.06 & ₹691.63 as on 7 Jan 2025, 2.30 'hrs' IST

$8.06

-0.09

(-1.1%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Iteos Therapeutics share price in Dollar and Rupees. Guide to invest in Iteos Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Iteos Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Iteos Therapeutics share price movements

  • Today's Low: $8.04
    Today's High: $8.29

    Day's Volatility :3.02%

  • 52 Weeks Low: $7.09
    52 Weeks High: $18.75

    52 Weeks Volatility :62.19%

Iteos Therapeutics Returns

PeriodIteos Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-13.57%
-8.4%
0.0%
6 Months
-46.06%
-3.8%
0.0%
1 Year
-26.84%
-0.1%
0.0%
3 Years
-80.5%
2.9%
-19.8%

Iteos Therapeutics Key Statistics

in dollars & INR

Previous Close
$8.15
Open
$8.19
Today's High
$8.29
Today's Low
$8.04
Market Capitalization
$280.6M
Today's Volume
$278.0K
52 Week High
$18.75
52 Week Low
$7.09
Revenue TTM
$35.0M
EBITDA
$-145.0M
Earnings Per Share (EPS)
$-3.14
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-0.89%
Return On Equity TTM
-19.72%

How to invest in Iteos Therapeutics from India?

It is very easy for Indian residents to invest directly in Iteos Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Iteos Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Iteos Therapeutics or ITOS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Iteos Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Iteos Therapeutics shares which would translate to 0.106 fractional shares of Iteos Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Iteos Therapeutics, in just a few clicks!

Returns in Iteos Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Iteos Therapeutics investment value today

Current value as on today

₹75,575

Returns

₹24,425

(-24.43%)

Returns from Iteos Therapeutics Stock

₹27,648 (-27.65%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Iteos Therapeutics

38%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Iteos Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 38% more investors are searching Iteos Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Iteos Therapeutics

  • BlackRock Inc

    10.21%

  • RA Capital Management, LLC

    8.72%

  • Boxer Capital LLC

    8.07%

  • Mpm Asset Management, LLC

    7.50%

  • TANG CAPITAL MANAGEMENT LLC

    6.59%

  • MPM Oncology Impact Management LP

    4.78%

Analyst Recommendation on Iteos Therapeutics

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Iteos Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Iteos Therapeutics

What analysts predicted

Upside of 210.17%

Current:

$8.06

Target:

$25.00

Insights on Iteos Therapeutics

  • Price Movement

    In the last 7 days, ITOS stock has moved up by 11.8%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, -11.30M → 35.0M (in $), with an average increase of 132.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -7.12M → -45.35M (in $), with an average decrease of 536.3% per quarter
  • ITOS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 47.5%
  • ITOS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 135.8%
  • Price to Sales

    ForITOS every $1 of sales, investors are willing to pay $9.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Iteos Therapeutics Technicals Summary

Sell

Neutral

Buy

Iteos Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Iteos Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Iteos Therapeutics Inc
-3.32%
-46.06%
-26.84%
-80.5%
-57.22%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Iteos Therapeutics Inc
39.55
NA
NA
-3.15
-0.2
-0.13
NA
17.29
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Iteos Therapeutics Inc
Buy
$280.6M
-57.22%
39.55
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Iteos Therapeutics

starting operations in 2012, iteos therapeutics is a clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by developing immunotherapies by design. iteos is developing eos200271, a clinical-stage potent and selective ido1 inhibitor with exceptional brain penetration. the company is also advancing eos100850, an insurmountable and non-brain penetrant adenosine a2a receptor antagonist, into a phase 1 trial in the second half of 2018; and a human adcc-enabling anti-tigit antibody (eos884448), representing an additional, third clinical entry in 2019. based in gosselies, belgium, iteos therapeutics was founded and supported in part by investments from the ludwig institute cancer research (licr), the walloon region of belgium and the european fund for economic and regional development (feder). for more information, please visit www.iteostherapeutics.com.
Organization
Iteos Therapeutics
Employees
157
CEO
Dr. Michel Detheux Ph.D.
Industry
Health Technology

Management People of Iteos Therapeutics

NameTitle
Dr. Michel Detheux Ph.D.
President, CEO & Director
Mr. Matthew Gall
Chief Financial Officer
Mr. Matthew A. Call M.B.A.
Chief Operating Officer
Dr. Yvonne McGrath Ph.D.
Chief Scientific Officer
Ms. Adi Osovsky
Executive Vice President of Legal
Mr. Philippe Brantegem
Executive Vice President of Human Resources
Dr. David Feltquate M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in Iteos Therapeutics from India :

What is Iteos Therapeutics share price today?

Iteos Therapeutics share price today stands at $8.06, Open: $8.19 ; Previous Close: $8.15 ; High: $8.29 ; Low: $8.04 ; 52 Week High: $18.75 ; 52 Week Low: $7.09. The stock opens at $8.19, after a previous close of $8.15. The stock reached a daily high of $8.29 and a low of $8.04, with a 52-week high of $18.75 and a 52-week low of $7.09.

Can Indians buy Iteos Therapeutics shares?

Yes, Indians can invest in the Iteos Therapeutics (ITOS) from India.

With INDmoney, you can buy Iteos Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Iteos Therapeutics at zero transaction cost.

How can I buy Iteos Therapeutics shares from India?

It is very easy to buy Iteos Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Iteos Therapeutics be purchased?

Yes, you can buy fractional shares of Iteos Therapeutics with INDmoney app.

What are the documents required to start investing in Iteos Therapeutics stocks?

To start investing in Iteos Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Iteos Therapeutics

Today’s highest price of Iteos Therapeutics (ITOS) is $8.29.

Today’s lowest price of Iteos Therapeutics (ITOS) is $8.04.

What is today's market capitalisation of Iteos Therapeutics

Today's market capitalisation of Iteos Therapeutics ITOS is 280.6M

What is the 52 Week High and Low Range of Iteos Therapeutics

  • 52 Week High

    $18.75

  • 52 Week Low

    $7.09

What are the historical returns of Iteos Therapeutics?

  • 1 Month Returns

    -3.32%

  • 3 Months Returns

    -46.06%

  • 1 Year Returns

    -26.84%

  • 5 Years Returns

    -57.22%

Who is the Chief Executive Officer (CEO) of Iteos Therapeutics

Dr. Michel Detheux Ph.D. is the current Chief Executive Officer (CEO) of Iteos Therapeutics.